Andlauer Healthcare Group Inc. (TSE:AND) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) have earned an average rating of “Moderate Buy” from the seven analysts that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is C$48.57.

AND has been the topic of several recent research reports. Scotiabank lifted their target price on shares of Andlauer Healthcare Group from C$43.00 to C$44.00 in a research report on Thursday, November 7th. TD Securities lifted their price target on shares of Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the stock a “buy” rating in a report on Thursday, November 7th.

Check Out Our Latest Stock Report on AND

Andlauer Healthcare Group Stock Performance

Shares of AND stock opened at C$46.20 on Tuesday. The firm has a market capitalization of C$863.94 million, a price-to-earnings ratio of 30.39 and a beta of 0.66. The company has a current ratio of 1.35, a quick ratio of 1.66 and a debt-to-equity ratio of 41.86. The business’s 50-day moving average price is C$43.07 and its 200-day moving average price is C$40.85. Andlauer Healthcare Group has a 12 month low of C$36.43 and a 12 month high of C$46.32.

About Andlauer Healthcare Group

(Get Free Report

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Articles

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.